Abstract: This invention relates to a process and apparatus for dyeing of textiles, to an immobilized enzyme comprised in said apparatus required for carrying out the process, and to a method to produce enzymatically indigo and derivatives thereof.

Abstract: The present disclosure relates to systems and methods for analysis of proteins, more in particular to nanopore systems, devices and methods for single-molecule protein analysis and sequencing. Provided is a method for translocating a target protein through a nanopore, the nanopore being comprised in a membrane separating a fluidic chamber of a nanopore system into a cis side and a trans side, comprising: (a) allowing a protein translocase in solution to capture and form a complex with the target protein to be translocated; (b) contacting the translocase-target protein complex with the cis side of the nanopore and allowing for translocation of the target protein to the trans side; wherein the nanopore system has a cis to trans electro-osmotic force (EOF) resulting from a large net ionic current flow cis-to-trans relative to the total ionic current flow, so that the target protein is captured in the nanopore with on top of the nanopore the translocase controlling the translocation.

Abstract: The present invention relates to a single cell cylindrical battery, such as a button cell or a button battery, that can be regarded to have the shape of a slice of a cylinder, and to a method preventing upper digestive and upper respiratory tract injury after accidental ingestion of the single cell cylindrical battery. It is noted that in some case ingestion has even led to the death in particular of children or small size adults, or people with a mental limitation, or people with a prior narrowing of structures in which the battery can be lodged. The structures in which the battery can be lodged are both the pharyngeal, upper digestive and upper respiratory tracts. As ingestion itself can not always be prevented, a relatively safe battery has been developed, which mitigates problems associated with ingestion.

Abstract: The invention relates to the field of nanopores, in particular to engineered Fragaceatoxin C (FraC) nanopores and their application in analyzing biopolymers and other (biological) compounds, such as single-molecule (protein) sequencing. Provided is a system comprising oligomeric FraC nanopores comprised in a lipid bilayer, wherein the sum of the nanopore fraction in the heptameric (Type II) state and the nanopore fraction in the hexameric (Type III) state represents at least 60% of the total number of FraC nanopores.

Abstract: An imaging device (100) comprises a stack of photoactive layers (11) including at least a p-type photoactive layer (11p) and an n-type photoactive layer (11n). The photoactive layers comprise quantum dots (QD) formed by semiconductor nanocrystals capped by ligands. Readout electronics comprise electrodes (13t, 13b) sandwiching the photoactive layers (11). At least one of the electrodes (13b) is divided in respective pixels (10p) for collecting photo-generated charges from respective parts of the photoactive layers. Each pixel (10p) comprises an amplification circuit to amplify the photo-generated charge, preferably using a DG-FET. An intermediate layer (11i) can be provided between the p- and n-type photoactive layers (11p, 11n).

Abstract: The invention relates to the field of medicine and medicinal chemistry, more in particular to the design, manufacture and use of anti-cancer drugs that can be activated by an external stimulus that can be applied in a spatiotemporal fashion. Provided herein is a compound having the chemical structure or a pharmaceutically acceptable salt thereof.

Abstract: For measuring quality of view over a visual field of view of an eye, during a measuring period, deviations between gaze positions and associated stimulus positions where the stimulus to be followed was displayed when the gaze position was detected and magnitudes of the registered deviations arte determined. For each field portion of a map of a visual field of view, quality of view is determined in accordance with a quality of view estimates of associated ones of the registered deviations of which the associated stimulus positions are located relative to the gaze position so that the associated stimulus positions are in that field portion. For each of the associated ones of the registered deviations, the quality of view is estimated in accordance with the magnitude of that associated one of the registered deviations and with magnitudes of at least preceding or succeeding ones of the registered deviations.

Abstract: The present invention relates to novel arginase inhibitors of formula (I). These novel compounds are useful in the treatment of diseases that are associated with arginase activity, such as asthma, allergic rhinitis and COPD (chronic obstructive pulmonary disease).

Abstract: The invention relates to the fields of biomaterials, tissue engineering and regenerative medicine. More specifically, it relates to biomaterial substrates having precise surface properties and the use thereof to investigate cell-material interactions. Provided is a cell culture system having a biomaterial substrate which has at least a first linear surface gradient oriented orthogonally to a second linear surface gradient, wherein the first gradient and the second gradient are selected from the group consisting of stiffness (S), (aligned) topography (T) and wettability (W). Also provided is a cell screening platform having a combination of at least two, preferably at least three, more preferably four distinct cell culture systems.

Abstract: The present invention relates to anti-CD 103 antibodies, as well as use of these antibodies in diagnosis, prognosis, monitoring, and treatment of diseases. Also disclosed is an imaging agent comprising the anti-CD 103 antibody and a detectable label, wherein the antibody either does not block CD 103 binding to E-cadherin or at least partially blocks CD 103 binding to E-cadherin. The methods of treatment involve administering the anti CD 103 antibody which may be optionally coupled to a cytotoxic agent. Diseases to be treated include e.g. Hairy Cell leukemia, HCLv, intestinal and extraintestinal lymphomas, enteropathy-associated T-cell lymphoma (EATL), T-lymphoblastic leukemia/lymphoma (T-ALL), T-cell prolymphocytic leukemia (T-PLL), adult T cell leukemia/lymphoma (ATLL), mycosis fungoides (ME), anaplastic large cell lymphoma ALCL, cutaneous T-cell lymphoma (CTCL), Sezary Syndrome (SS), Alzheimer's disease, Parkinson's disease or multiple sclerosis.

Abstract: A computer program product for gathering respondent input for determining a ranking of states each characterized by a set of selected levels each associated to an attribute. The interface mechanism provides for inputting selected attribute levels of a respondent state and for ranking of comparable alternative states determined in response to the inputted respondent state, in comparison with that respondent state. The alternative states are each displayed as the set of attributes with the associated set of alternative levels simultaneously and with an input field for inputting a preference indication of the shown alternative state compared with the respondent state. This allows the respondent input to be entered with very few input actions and little switching between screens. Only the selected attribute levels of the respondent state and the rankings and identifications of the determined alternative states need to be transmitted to the central computer.

Abstract: A method for the in situ derivatization of at least one biogenic amine, precursor, or metabolite thereof in an isolated aqueous sample includes the steps of: (i) contacting the sample with a propionic anhydride/acetonitrile solution in the presence of a phosphate buffer having a pH in the range of 7.0 to 9.0 and allowing the conversion of amine and/or hydroxyl moieties of the biogenic amine, precursor, or metabolite thereof to form a propionyl derivative of the biogenic amine; followed by (ii) adding to the reaction mixture obtained in step (i) a carbodiimide compound and an electrophilic amine-containing compound, and allowing the carbodiimide-mediated derivatization of carboxylic acid moieties of the biogenic amine, precursor, or metabolite thereof.

Abstract: The invention relates generally to the field of nanopores and the use thereof in various applications, such as analysis of biopolymers and macromolecules, typically by making electrical measurements during translocation through a nanopores. Provided is a system comprising a funnel-shaped proteinaceous nanopore comprising an a-helical pore-forming toxin that is a member from the actinoporin protein family, more in particular Fragaceatoxin C (FraC), a mutant FraC, a FraC paralog, or a FraC homolog.

Abstract: A method for detecting an analyte in a sample includes the steps of obtaining a nanopore sensor comprising a nanopore and a protein adaptor internalized in the lumen of the nanopore, adding a sample comprising an analyte to the cis side or the trans side of the nanopore, and measuring conductance across the nanopore. A change in conductance after adding the sample indicates the analyte is present in the sample and has bound to the protein adaptor. Nanopore sensors comprise a nanopore and a protein adaptor internalized in the lumen of the nanopore. The protein adaptor is a functional enzyme or ligand-binding protein.

Abstract: A method for the in situ derivatization of at least one biogenic amine, precursor, or metabolite thereof in an isolated aqueous sample includes the steps of: (i) contacting the sample with a propionic anhydride/acetonitrile solution in the presence of a phosphate buffer having a pH in the range of 7.0 to 9.0 and allowing the conversion of amine and/or hydroxyl moieties of the biogenic amine, precursor, or metabolite thereof to form a propionyl derivative of the biogenic amine; followed by (ii) adding to the reaction mixture obtained in step (i) a carbodiimide compound and an electrophilic amine-containing compound, and allowing the carbodiimide-mediated derivatization of carboxylic acid moieties of the biogenic amine, precursor, or metabolite thereof.

Abstract: A sensor cartridge contains a porous matrix for passing analyte molecules of a liquid sample. A porous collection disk supports the matrix and closes a lower end of a wall of the cartridge. The collection disk being sandwiched between the lower end and a base cap. An air channel extends between a first air opening at a top end of the cartridge and a second air opening positioned above the collection disk and opposite a base cap air opening. The collection disk is between the second air opening and the base cap air opening. At least one of the first air openings and the base cap air opening comprises a connection to a supra-atmospheric or subatmospheric pressure air source. The second air opening and the base cap air opening guide an air flow to provide evaporation and analyze concentration at specific locations of the collection disk, thereby improving detection limits.

Abstract: The invention relates to methods, reagents and kits for detecting the susceptibility to cervical cancer. In particular, it relates to novel methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3 (CIN2/3) and the use thereof for identifying a cervical cell as neoplastic or predisposed to neoplasia in an isolated sample.

Abstract: The invention is directed to a method and a surgical instrument, typically a surgical stapler that is configured for performing anastomosis of a first gastro-intestinal tract section to a second gastro-intestinal tract section, both gastro-intestinal tract sections comprising a superficial layer and an intermediate layer. Said method comprises contacting the superficial layers of said gastro-intestinal tract sections and compressing the contacted sections between a first pressure area and a second pressure area, wherein the sum of the first pressure area and the second pressure increases during the compression such that the superficial layers are pressed aside and the intermediate layers are contacted.

Abstract: A method for detecting an analyte in a sample includes the steps of obtaining a nanopore sensor comprising a nanopore and a protein adaptor internalized in the lumen of the nanopore, adding a sample comprising an analyte to the cis side or the trans side of the nanopore, and measuring conductance across the nanopore. A change in conductance after adding the sample indicates the analyte is present in the sample and has bound to the protein adaptor. Nanopore sensors comprise a nanopore and a protein adaptor internalized in the lumen of the nanopore. The protein adaptor is a functional enzyme or ligand-binding protein.

Abstract: The invention provides an underwater energy storage system (UW-ES system) comprising a reservoir structure (5), which is resting at the bottom (4) of a waterbody (1), such as a sea, an ocean, a waterway, etc. The reservoir structure has a pressurizing reservoir (7A, 7B) with a deformable wall structure (17A, 17B) and a depressurizing reservoir (8A, 8B) with a rigid wall structure (6, 14, 18A, 18B), which are holding a working liquid (9) separated from the water (2) of the water body. Energy is stored and retrieved by displacing part of the working liquid from the depressurizing reservoir into the pressurizing reservoir, and vice versa, respectively. Therein use is made of the hydrostatic pressure of the water (2) acting on the deformable wall structure of the pressurizing reservoir. The UW-ES system is compact and economical, and allows for highly synergistical integration with various power take-off systems.